Key points from article :
Beta Bionics partners with Zealand Pharma to test a dual-hormone artificial pancreas system.
Wearable bionic pancreas iLet uses artificial intelligence to deliver insulin and glucagon analogues.
Plans to use dasiglucagon, a ready-to-use glucagon analogue developed by Zealand Pharma.
Home-use-trials to be done on insulin only configuration versus bihormonal configuration.
Effect on glycaemic control, quality of life and treatment satisfaction will be evaluated.
Could pave way to fully automated diabetes care for people living with type 1 diabetes.
